Clinical trial
A Randomized, Double-Blind, Controlled Study to Assess the Efficacy and Safety of Intravenous Phenobarbital in Neonatal Seizures
NCT04320940 is registered in ClinicalTrials.gov with NEMA Research, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Controlled Study to Assess the Efficacy and Safety of Intravenous Phenobarbital in Neonatal Seizures
- Lead sponsor
- NEMA Research, Inc.
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- March 12, 2021
- Completion date
- February 1, 2023
- Enrollment
- 4 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.